Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules

Details for Australian Patent Application No. 2006278227 (hide)

International Classifications

Event Publications

7 February 2008 PCT application entered the National Phase

PCT publication WO2007/019573 Priority application(s): WO2007/019573

28 February 2008 Corrigenda

PCT applications that have entered the National Phase - Name Index Under the name Ares Trading S.A. and Zymogenetics, Inc., Application No. 2006278227, Under INID (54), correct the title to Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules.

20 October 2011 Application Accepted

Published as AU-B-2006278227

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.